Clinical Trial Detail

NCT ID NCT03009981
Title A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Apalutamide + Degarelix + Prednisone

Apalutamide + Degarelix

Degarelix

Age Groups: senior adult

No variant requirements are available.